fibromyalgia
FIBROMYALGIA
Treatment Guideline Chart

Fibromyalgia is a clinical syndrome wherein the patient experiences generalized pain and fatigue that cannot be explained by the presence of any other disorder.
It is often considered to be psychosomatic or psychogenic in nature.
It is found in approximately 2% of the population and the prevalence increases with age, most common in women 20-55 year of age

Fibromyalgia References

  1. Arnold LM. The pathophysiology, diagnosis and treatment of fibromyalgia. Psychiatr Clin N Am. 2010 Jun;33(2):375-408. doi: 10.1016/j.psc.2010.01.001. PMID: 20385343
  2. Carville SF, Arendt-Nielsen S, Bliddal H, et al. EULAR evidence based recommendations for the management of fibromyalgia syndrome. Jul 20, 2007. Ann Rheum Dis. 2008 Apr;67(4):536-541. http://ard.bmj.com/cgi/content/abstract/ard.2007.071522v1. PMID: 17644548
  3. Fitzcharles MA, Ste-Marie PA, Goldenberg DL, et al. 2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: Executive summary. Pain Res Manag. 2013 Jun;18(3):119-126. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3673928/pdf/prm18119.pdf. PMID: 23748251
  4. Hasset AL, Gevirtz RN. Nonpharmacologic treatment for fibromyalgia: patient education, cognitive-behavioral therapy, relaxation techniques, and complementary and alternative medicine. Rheum Dis Clin N Am. 2009 May;35(2):393-407. doi: 10.1016/j.rdc.2009.05.003. PMID: 19647150
  5. Jones KD, Liptan GL. Exercise interventions in fibromyalgia: clinical applications from the evidence. Rheum Dis Clin N Am. 2009 May;35(2):373-391. doi: 10.1016/j.rdc.2009.05.004. PMID: 19647149
  6. Wolfe F, Clauw DJ, Fitzcharles M, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Research (Hoboken). 2010 May;62(5):600-610. doi: 10. doi: 10.1002/acr.20140. PMID: 20461783
  7. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum. 1990 Feb;33(2):160-172. PMID: 2306288
  8. Mease PJ, Choy EH. Pharmacotherapy of fibromyalgia. Rheum Dis Clin N Am. 2009 May;35(2):359-372. doi: 10.1016/j.rdc.2009.06.007. PMID: 19647148
  9. Wolfe F, Rasker JJ. Fibromyalgia. In: Firestein GS, Budd RC, Harris ED Jr, et al. Kelley's Textbook of Rheumatology. 8th. Philadelphia, PA: Elsevier Inc; 2009.
  10. Goldenberg D. Clinical manifestations and diagnosis of fibromyalgia in adults. UpToDate. http://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-fibromyalgia-in-adults. Aug 2013. Accessed 06 Jun 2011.
  11. National Guideline Clearinghouse (NGC). Guideline summary: Guideline for the management of fibromyalgia syndrome pain in adults and children. National Guideline Clearinghouse. http://www.guideline.gov. 2005.
  12. University of Texas, School of Nursing, Family Nurse Practitioner Program. Management of fibromyalgia syndrome in adults. National Guideline Clearing House (NGC). http://www.guideline.gov/content.aspx?id=14869. May 2005
  13. Winfield JB. Fibromyalgia. eMedicine. http://emedicine.medscape.com/article/329838-overview.Accessed 10 Jun 2011
  14. Goldenberg D. Treatment of fibromyalgia in adults not responsive to initial therapies. UptoDate Web Site. http://www.uptodate.com/contents/treatment-of-fibromyalgia-in-adults-not-responsive-to-initial-therapies. Jan 2014. Accessed 06 Jun 2011.
  15. Goldenberg D. Initial treatment of fibromyalgia in adults. UptoDate Web Site. http://www.uptodate.com/contents/initial-treatment-of-fibromyalgia-in-adults. Jan 2014.
  16. Dymon T. Fibromyalgia. In: Dong BJ, Elliott DP, eds. Neurologic and Psychiatric Care I. Lexena, KS: American College of Clinical Pharmacy; 2015:5-18.
  17. Forte ML, Butler M, Andrade KE, Vincent A, Schousboe JT, Kane RL. Treatments for fibromyalgia in adult subgroups [Internet]. AHRQ Comparative Effectiveness Reviews. Rockville, MD: Agency for Healthcare Research and Quality (US); 2015 Jan. http://www.ncbi.nlm.nih.gov/books/NBK274474/pdf/Bookshelf_NBK274474.pdf.
  18. Ablin J, Fitzcharles MA, Buskila D, et al. Treatment of fibromyalgia syndrome: recommendations of recent evidenced-based interdisciplinary guidelines with special emphasis on complementary and alternative therapies. Evid Based Complement Alternat. 2013. doi: 10.1155/2013/485272. PMID: 24348701
  19. Bazzichi L, Giacomelli C, Atzeni F, et al. One year in review: Fibromyalgia. Clin Exp Rheumatol. 2016 Jun;34(2)(Suppl 96):S145-149. PMID: 27157400
  20. Cruccu G, Garcia-Larrea L, Hanson P, et al. EAN guidelines on central neurostimulation therapy in chronic pain conditions. Eur J Neurol. 2016 Oct;23(10):1489-1499. doi: 10.1111/ene.13103. PMID: 27511815
  21. Goldenberg, DL. Initial treatment of fibromyalgia in adults. UpToDate. http://www.uptodate.com. 06 Nov 2018.
  22. Goldenberg, DL. Treatment of fibromyalgia in adults not responsive to initial therapies. UpToDate. http://www.uptodate.com. 19 Jun 2018.
  23. Häuser W, Fitzcharles M. Facts and myths pertaining to fibromyalgia. Dialogues Clin Neurosci. 2018 Mar;20(1):53-62. PMID: 29946212
  24. Higgs JB. Fibromyalgia in Primary Care. Prim Care. 2018 Jun;45(2):325-341. doi: 10.1016/j.pop.2018.02.008. PMID: 29759127
  25. Jay GW, Barkin RL. Fibromyalgia. Dis Mon. 2015 Mar;61(3):66-111. doi: 10.1016/j.disamonth.2015.01.002. PMID: 25769552
  26. Kia S, Choy E. Update on treatment guideline in fibromyalgia syndrome with focus on pharmacology. Biomedicines. 2017 May;5(2). doi: 10.3390/biomedicines5020020. PMID: 28536363
  27. Macfarlane GJ, Kronisch C, Dean LE, et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. 2017 Feb;76(2):318-328. doi: 10.1136/annrheumdis-2016-209724. PMID: 27377815
  28. Talotta R, Bazzichi L, Di Franco M, et al. One year in review 2017: fibromyalgia. Clin Exp Rheumatol. 2017 Jun;35(3)(Suppl 105):6-12. PMID: 28681712
  29. Turk DC, Vierck CJ, Scarbrough E, et al. Fibromyalgia: combining pharmacological and nonpharmacological approaches to treating the person, not just the pain. The Journal of Pain. 2008 Feb;9(2):99-104. doi: 10.1016/j.jpain.2007.08.006.
  30. Wolfe f, Clauw DJ, Fitzcharles MA, et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016 Dec;46(3):319-329. doi: 10.1016/j.semarthrit.2016.08.012. PMID: 27916278
  31. Ariani A, Bazzichi L, Sarzi-Puttini P, et al. The Italian Society for Rheumatology clinical practice guidelines for the diagnosis and management of fibromyalgia: best practices based on current scientific evidence. Reumatismo. 2021 Aug 3;73(2):89-105. doi: 10.4081/reumatismo.2021.1362. Accessed 14 Nov 2022. PMID: 34342210.
  32. Bhargava J, Hurley JA. Fibromyalgia. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 10 Oct 2022. Accessed 21 Nov 2022.
  33. Boomershine CS. Fibromyalgia. eMedicine. http://www.emedicine.com. 14 Sep 2021. Accessed 15 Nov 2022.
  34. Centers for Disease Control and Prevention. Fibromyalgia. http://www.cdc.gov. 06 Jan 2020. Accessed 12 Dec 2022.
  35. Chakrabarty S, Zoorob R. Fibromyalgia. Am Fam Physician. 2007 Jul 15;76(2):247-54. Accessed 15 Dec 2022. PMID: 17695569.
  36. ClinicalKey. Clinical overview: fibromyalgia. ClinicalKey. https://www.clinicalkey.com. 03 May 2022. Accessed 09 Dec 2022.
  37. Diaz-Piedra C, Catena A, Sánchez AI, et al. Sleep disturbances in fibromyalgia syndrome: the role of clinical and polysomnographic variables explaining poor sleep quality in patients. Sleep Med. 2015 Aug;16(8):917-25. doi: 10.1016/j.sleep.2015.03.011. Accessed 05 Jan 2023. PMID: 26070854.
  38. El Miedany Y, Gadallah N, Mohasseb D, et al. Consensus evidence-based clinical practice recommendations for the management of fibromyalgia. Egypt Rheumatol Rehabil. 2022;49(30):1-11. https://doi.org/10.1186/s43166-022-00129-x. Accessed 15 Dec 2022.
  39. Galvez-Sánchez CM, Reyes del Paso GA. Diagnostic criteria for fibromyalgia: critical review and future perspectives. J Clin Med. 2020 Apr 23;9(4):1219. doi: 10.3390/jcm9041219. Accessed 25 Nov 2022. PMID: 32340369.
  40. Gilron I, Jensen TS, Dickenson AH. Combination pharmacotherapy for management of chronic pain: from bench to bedside. Lancet Neurol. 2013 Nov;12(11):1084-1095. doi: 10.1016/S1474-4422(13)70193-5. Accessed 15 Dec 2022. PMID: 24074723.
  41. Goldenberg, DL. Differential diagnosis of fibromyalgia. UpToDate. http://www.uptodate.com. 17 May 2022. Accessed 17 Nov 2022.
  42. Häuser W, Thieme K, Turk DC. Guidelines on the management of fibromyalgia syndrome - a systematic review. Eur J Pain. 2010 Jan;14(1):5-10. doi: 10.1016/j.ejpain.2009.01.006. Accessed 28 Nov 2022. PMID: 19264521.
  43. Goldenberg, DL. Pathogenesis of fibromyalgia. UpToDate. http://www.uptodate.com. 29 Sep 2022. Accessed 17 Nov 2022.
  44. Heymann RE, Paiva ES, Martinez JE, et al. New guidelines for the diagnosis of fibromyalgia. Rev Bras Reumatol Engl Ed. 2017;57 Suppl 2:467-476. doi: 10.1016/j.rbre.2017.07.002. Accessed 28 Nov 2022. PMID: 28800969.
  45. Kang J, Choi S, Park D, et al. Disentangling diagnosis and management of fibromyalgia. J Rheum Dis 2022 Jan; 29(1): 4-13. Accessed 14 Dec 2022.
  46. Kwiatek R. Treatment of fibromyalgia. Aust Prescr. 2017;40(5):179-183. doi:10.18773/austprescr.2017.056. Accessed 04 Jan 2023.
  47. Millea PJ, Holloway RL. Treating fibromyalgia. Am Fam Physician. 2000 Oct;62(7):1575-1582, 1587. Accessed 22 Nov 2022. PMID: 11037075.
  48. Moret C, Briley M. Antidepressants in the treatment of fibromyalgia. Neuropsychiatr Dis Treat. 2006 Dec;2(4):537-548. doi: 10.2147/nedt.2006.2.4.537. Accessed 04 Jan 2023. PMID: 19412502.
  49. Moukaddem A, Chaaya M, Slim ZFN, et al. Fibromyalgia: epidemiology and risk factors, a population-based case-control study in Lebanon. Int J Rheum Dis. 2017 Feb;20(2):169-176. doi: 10.1111/1756-185X.12701. Accessed 16 Nov 2022. PMID: 26172074.
  50. Puccio FA, Rojas R, Mosquera I, et al. Food allergy is an important diseases associated to fibromyalgia. Clin Transl Allergy. 2013;3(S3). doi:10.1186/2045-7022-3-s3-p120. Accessed 28 Nov 2022.
  51. Rosenfeld VW, Rutledge DN, Stern JM. Polysomnography with quantitative EEG in patients with and without fibromyalgia. J Clin Neurophysiol 2015;32:164–170. Accessed 10 Jan 2023.
  52. Royal College of Physicians. The diagnosis of fibromyalgia syndrome: UK clinical guidelines. London, UK: Royal College of Physicians; 2022. Accessed 21 Nov 2022.
  53. Slotkoff AT, Radulovic DA, Clauw DJ. The relationship between fibromyalgia and the multiple chemical sensitivity syndrome. Scand J Rheumatol. 1997;26(5):364-367. doi: 10.3109/03009749709065700. Accessed 25 Nov 2022. PMID: 9385348.
  54. Smith HS, Bracken D, Smith JM. Pharmacotherapy for fibromyalgia. Front Pharmacol. 2011 Mar 31;2:17. doi: 10.3389/fphar.2011.00017. Accessed 25 Nov 2022. PMID: 21772818.
  55. Stournaras D, Petrovic K. Fibromyalgia treatment and management considerations for nurse practitioners. J Am Assoc Nurse Pract. 2019 Jun 5;31(6):371-377. doi: 10.1097/JXX.0000000000000178. Accessed 14 Dec 2022. PMID: 30829972.
  56. Tabra SAA, Abu-Zaid MH, Aboelhawa M, et al. The effect of combined pregabalin and Duloxetine in functional status, quality of life and psychological status in fibromyalgia. Ann Rheum Dis. 2019 Jun. doi: 10.1136/annrheumdis-2019-eular.170. Accessed 11 Jan 2023.
Editor's Recommendations
Special Reports